RRML - Invasive aspergillosis in hematology malignancies

RRML - Invasive aspergillosis in hematology malignancies – a disease difficult to diagnose

Main page
News
RJLabM Credits
Archive
- Current issue
- Ahead of print
- List of published issues
- 2024
  - Nr.1/2024
- 2023
  - Nr.4/2023
  - Nr.3/2023
  - Nr.2/2023
  - Nr.1/2023
  - Supplement 1/2023
- 2022
  - Nr.4/2022
  - Nr.3/2022
  - Nr.2/2022
  - Nr.1/2022
  - Supplement 1/2022
- 2021
  - Nr.4/2021
  - Nr.3/2021
  - Nr.2/2021
  - Nr.1/2021
- 2020
  - Nr.4/2020
  - Nr.3/2020
  - Nr.2/2020
  - Nr.1/2020
  - Supplement 1/2020
- 2019
  - Nr.4/2019
  - Nr.3/2019
  - Nr.2/2019
  - Nr.1/2019
  - Supplement 1/2019
- 2018
  - Nr.4/2018
  - Nr.3/2018
  - Nr.2/2018
  - Nr.1/2018
  - Supplement 1/2018
  - Supplement 2/2018
  - Supplement 3/2018
- 2017
  - Nr.4/2017
  - Nr.3/2017
  - Nr.2/2017
  - Nr.1/2017
  - Supplement 1/2017
- 2016
  - Nr.4/2016
  - Nr.3/2016
  - Nr.2/2016
  - Nr.1/2016
  - Supplement 1/2016
- 2015
  - Nr.4/2015
  - Nr.3/2015
  - Nr.2/2015
  - Nr.1/2015
  - Supplement 1/2015
- 2014
  - Nr.4/2014
  - Nr.3/2014
  - Nr.2/2014
  - Nr.1/2014
  - Supplement 1/2014
- 2013
  - Nr.4/2013
  - Nr.3/2013
  - Nr.2/2013
  - Nr.1/2013
  - Supplement 1/2013
- 2012
  - Nr.4/2012
  - Nr.3/2012
  - Nr.2/2012
  - Nr.1/2012
  - Supplement 1/2012
- 2011
  - Nr.4/2011
  - Nr.3/2011
  - Nr.2/2011
  - Nr.1/2011
  - Supplement 1/2011
- 2010
  - Nr.4/2010
  - Nr.3/2010
  - Nr.2/2010
  - Nr.1/2010
  - Supplement 1/2010
- 2009
  - Nr.4/2009
  - Nr.3/2009
  - Nr.2/2009
  - Nr.1/2009
  - Supplement 1/2009
- 2008
  - Nr.4/2008
  - Nr.3/2008
  - Nr.2/2008
  - Nr.1/2008
  - Supplement 1/2008
- 2007
  - Nr.4/2007
  - Nr.3/2007
  - Nr.2/2007
  - Nr.1/2007
- 2006
  - Nr.4/2006
  - Nr.3/2006
  - Nr.2/2006
  - Nr.1/2006
- 2005
  - Nr.1/2005
Instructions for authors
Online applications
- Send an article
- Online payments
Editorial
About us
Links

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Top 10 downloaded articles - April 2024 -

A comprehensive review of Prof...	25
Recomandarea comună EFLM-COLA...	15
Anti-thyroid peroxidase (TPO) ...	11
Understanding the key differen...	10
Monocyte to high-density lipop...	10
Romanian Review of Laboratory ...	7
Approaching Risk Management in...	7
Understanding the pathogenesis...	7
Predictive value of expression...	7
Function of the S1P pathway in...	6

Concept, Design & Programming
Dr. Adrian Man

Nr. 20(1)/2012

Invasive aspergillosis in hematology malignancies – a disease difficult to diagnose

Alina Tănase, Anca Coliţă, Daniel Coriu, Carmen Orban, Ligia Barbarii, Adrian Streinu-Cercel

Abstract:

Invasive fungal infections are a major threat to immunocompromised patients, particularly those with hematological malignancies and hematopoietic stem-cell transplant. Invasive aspergillosis (IA) represents the main cause of infections after hematopoietic stem cell transplant, with a high mortality rate among these patients. Clinical signs and symptoms of IA are non-specific. The traditional laboratory techniques have low sensitivity and late results, and thus a limited role in the diagnosis of IA. Therefore, improving the specific diagnosis of IA has become a common medical concern. Indirect mycological tests (detecting fungal antigens in serum) are useful instruments for early diagnosis of IA and they were widely studied. Galactomanan antigen (GM) Assay, which is the most standardized parameter, was implemented in Fundeni Clinical Institute starting Jan. 2011, as a routine test. First preliminary data suggest that, due to this test, an increased number of invasive aspergillosis was diagnosed in high risk patients.

Keywords: invasive aspergillosis,hematological malignancies,allogenic stem cell transplant,galactomanan

Download full text PDF
(103 KB)

Tănase A, Coliţă A, Coriu D, Orban C, Barbarii L, Streinu-Cercel A. Invasive aspergillosis in hematology malignancies – a disease difficult to diagnose. Rev Romana Med Lab. 2012;20(1):7-14